Cardiovascular disease (CVD) remains the leading cause of death and disability worldwide.
While many factors can contribute to CVD, atherosclerosis is the cardinal underlying …

Circulating cell-free DNA and its association with cardiovas... : Current Opinion in Lipidology
Circulating cell-free DNA and its association with cardiovascular disease: what we know and …

Background: Secondary prevention lifestyle and pharmacological treatment of
atherosclerotic cardiovascular disease (ASCVD) reduce a high proportion of recurrent …

Background A fixed-dose combination of phentermine and extended-release topiramate
(PHEN/TPM-approved for weight management) has demonstrated in-clinic reduction of …

Abstract Introduction and Objectives Subjects without cardiovascular (CV) disease (CVD)
may suffer from subclinical atherosclerosis, and are at increased risk for atherosclerotic CV …

Objective The relationship between the level of baseline risk factor control and
cardiovascular outcomes in hypertensive patients with blood pressure intervention is not …

The associations of cardiovascular disease (CVD) with comorbidities and biochemical and
body composition measurements are repeatedly described but have not been studied …

As a biomarker of acute myocardial infarction (AMI), screening for cardiac troponin I (cTnI)
has extremely high clinical sensitivity and specificity, and is extremely important for early …

Purpose This study explores the relationship between depression and cardiovascular
disease (CVD) in the US adult population, focusing on sex differences. Design Cross …

The aim of this review was to perform a critical appraisal of serum inflammatory biomarkers
used for the prediction of cardiovascular disease (CVD) risk. We conducted a systematic …